{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:29:05Z","timestamp":1774049345642,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["956185"],"award-info":[{"award-number":["956185"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["956185"],"award-info":[{"award-number":["956185"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["956185"],"award-info":[{"award-number":["956185"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000643","name":"Daphne Jackson Trust","doi-asserted-by":"publisher","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}],"id":[{"id":"10.13039\/501100000643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["Starter Grant for Clinical Lecturers"],"award-info":[{"award-number":["Starter Grant for Clinical Lecturers"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spinal muscular atrophy (SMA) is an autosomal recessive childhood-onset neuromuscular disease with a carrier frequency of ~1:50. Mitochondrial abnormalities are widespread in patients with SMA. Disease carriers for SMA (i.e., the parents of patients with SMA) are viewed as asymptomatic for SMA disease. As far as we are aware, mitochondria have not been previously examined in SMA carriers, yet as they are maternally inherited, mitochondrial function in SMA carriers has putative implications for disease pathogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fibroblast cell lines derived from SMA carriers and controls were obtained from two different sources and cultured under standard conditions. The mitochondrial membrane potential, reactive oxygen species (ROS) production, citrate synthase activity, and bioenergetic analysis were examined as measures of mitochondrial function. The mitochondrial genome was also sequenced in a subset of the fibroblast cell lines to identify any mitochondrial DNA variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here, we show a depolarized mitochondrial membrane potential, increased levels of reactive oxygen species, and reduced citrate synthase activity in SMA carriers compared with controls. A likely pathogenic variant in the <jats:italic>MT-CO3<\/jats:italic> gene (which encodes subunit III of cytochrome c oxidase) was also identified in a paternal carrier.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study was conducted as a preliminary investigation of mitochondrial function in SMA carriers. Our findings suggest that disease carriers of SMA show differences in mitochondrial function, indicative of a subclinical mitochondrial phenotype. Further investigation in a larger sample set is warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-024-00515-w","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:02:18Z","timestamp":1715796138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Altered mitochondrial function in fibroblast cell lines derived from disease carriers of spinal muscular atrophy"],"prefix":"10.1038","volume":"4","author":[{"given":"Rachel","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4525-7059","authenticated-orcid":false,"given":"Kiterie M. E.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2330-9444","authenticated-orcid":false,"given":"Ewout J. N.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-5191","authenticated-orcid":false,"given":"Brunhilde","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-5577","authenticated-orcid":false,"given":"Thomas H.","family":"Gillingwater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri, E. et al. Spinal muscular atrophy. Nat. Rev. Dis. Primers 8, 52 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman, E. A. et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur. J. Hum. Genet. 20, 27\u201332 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrneurol.2018.4","volume":"14","author":"EJN Groen","year":"2018","unstructured":"Groen, E. J. N., Talbot, K. & Gillingwater, T. H. Advances in therapy for spinal muscular atrophy: promises and challenges. Nat. Rev. Neurol. 14, 214\u2013224 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00018-021-03819-5","volume":"78","author":"R James","year":"2021","unstructured":"James, R. et al. Revisiting the role of mitochondria in spinal muscular atrophy. Cell Mol. Life Sci. 78, 4785\u20134804 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1093\/hmg\/ddw262","volume":"25","author":"N Miller","year":"2016","unstructured":"Miller, N. et al. Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Hum. Mol. Genet. 25, 3395\u20133406 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0070-2153(06)77002-8","volume":"77","author":"R Dumollard","year":"2007","unstructured":"Dumollard, R., Duchen, M. & Carroll, J. The role of mitochondrial function in the oocyte and embryo. Curr. Top Dev. Biol. 77, 21\u201349 (2007).","journal-title":"Curr. Top Dev. Biol."},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2144\/000113610","volume":"50","author":"SW Perry","year":"2011","unstructured":"Perry, S. W. et al. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50, 98\u2013115 (2011).","journal-title":"Biotechniques"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"e0247234","DOI":"10.1371\/journal.pone.0247234","volume":"16","author":"N Zaibi","year":"2021","unstructured":"Zaibi, N., Li, P. & Xu, S. Z. Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells. PLoS One 16, e0247234 (2021).","journal-title":"PLoS One"},{"key":"515_CR9","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.1984","volume":"6","author":"EA Orellana","year":"2016","unstructured":"Orellana, E. A. & Kasinski, A. L. Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation. Bio. Protoc. 6, e1984 (2016).","journal-title":"Bio. Protoc."},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.200611141","volume":"177","author":"G Cumming","year":"2007","unstructured":"Cumming, G., Fidler, F. & Vaux, D. L. Error bars in experimental biology. J. Cell Biol. 177, 7\u201311 (2007).","journal-title":"J. Cell Biol."},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2014.01.011","volume":"19","author":"J Yun","year":"2014","unstructured":"Yun, J. & Finkel, T. Mitohormesis. Cell Metab. 19, 757\u2013766 (2014).","journal-title":"Cell Metab."},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s42255-021-00392-w","volume":"3","author":"GA Timblin","year":"2021","unstructured":"Timblin, G. A. et al. Mitohormesis reprogrammes macrophage metabolism to enforce tolerance. Nat. Metab. 3, 618\u2013635 (2021).","journal-title":"Nat. Metab."},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.201402104","volume":"205","author":"LA Kane","year":"2014","unstructured":"Kane, L. A. et al. PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143\u2013153 (2014).","journal-title":"J. Cell Biol."},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI71318","volume":"124","author":"TM Wishart","year":"2014","unstructured":"Wishart, T. M. et al. Dysregulation of ubiquitin homeostasis and \u03b2-catenin signaling promote spinal muscular atrophy. J. Clin. Invest. 124, 1821\u20131834 (2014).","journal-title":"J. Clin. Invest."},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"192ra85","DOI":"10.1126\/scitranslmed.3006055","volume":"5","author":"S Kalghatgi","year":"2013","unstructured":"Kalghatgi, S. et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells. Sci. Transl. Med. 5, 192ra85 (2013).","journal-title":"Sci. Transl. Med."},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ng0496-410","volume":"12","author":"JA Keightley","year":"1996","unstructured":"Keightley, J. A. et al. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nat. Genet. 12, 410\u2013416 (1996).","journal-title":"Nat. Genet."},{"key":"515_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman, G. S. et al. Mitochondrial diseases. Nat. Rev. Dis. Primers 2, 16080 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/hmg\/ddn150","volume":"17","author":"N Ashley","year":"2008","unstructured":"Ashley, N. et al. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations. Hum. Mol. Genet. 17, 2496\u20132506 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1111\/febs.16413","volume":"289","author":"SA Pinho","year":"2022","unstructured":"Pinho, S. A. et al. Mitochondrial and metabolic remodelling in human skin fibroblasts in response to glucose availability. FEBS J. 289, 5198\u20135217 (2022).","journal-title":"FEBS J."},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s43587-022-00191-2","volume":"2","author":"T Lima","year":"2022","unstructured":"Lima, T. et al. Pleiotropic effects of mitochondria in aging. Nat. Aging 2, 199\u2013213 (2022).","journal-title":"Nat. Aging"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41583-018-0091-3","volume":"20","author":"M Khacho","year":"2019","unstructured":"Khacho, M., Harris, R. & Slack, R. S. Mitochondria as central regulators of neural stem cell fate and cognitive function. Nat. Rev. Neurosci. 20, 34\u201348 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"13852","DOI":"10.1074\/jbc.REV118.000828","volume":"294","author":"A Bahat","year":"2019","unstructured":"Bahat, A. & Gross, A. Mitochondrial plasticity in cell fate regulation. J. Biol. Chem. 294, 13852\u201313863 (2019).","journal-title":"J. Biol. Chem."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00515-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00515-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00515-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:10:04Z","timestamp":1715796604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00515-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1038\/s43856-024-00515-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: T.H.G. has provided advisory services to Roche and Novartis. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}